SOAT1 and systemic lupus erythematosus: These characters make EBI2 a precisely controlled GPCR at its expression and signaling levels by IFN‐related regulators (i.e., IFN‐γ, oxysterol, STAT, IFN‐I, and ISGs) during the development of SLE.